Skip to main content
Caplight Logo









Hangzhou Sneuro Medical Technology Co., Ltd.

Hangzhou Sneuro Medical Technology Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://www.seeneuro.com/

Last Round

Series C

Mar 17, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Hangzhou Sneuro Medical Technology Co., Ltd. is a medical device company that develops and produces implantable neural stimulation and brain-computer interface technologies for patients with conditions such as chronic pain, epilepsy, and heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

neuromodulationbrain-computer interfaceBCIimplantable medical devicespinal cord stimulationSCSperipheral nerve stimulationPNStibial nerve stimulationTNSneurotechbioelectronicspain managementminimally invasive surgerymedical IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hangzhou Sneuro Medical Technology Co., Ltd. Comparables

Compare Hangzhou Sneuro Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Hangzhou Sneuro Medical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rishena Medical
87%
Cortex, Inc.
83%
Beijing PINS Medical Co., Ltd.
80%

Hangzhou Sneuro Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 17, 2026
Series B ExtensionApr 18, 2024
Series BOct 24, 2022
Series AJan 5, 2022
Pre SeedOct 15, 2021

Hangzhou Sneuro Medical Technology Co., Ltd. Investors

Notable investors and investment history

Hangzhou Sneuro Medical Technology Co., Ltd. investors
InvestorRounds
BioTrack CapitalSeries C, Series B Extension, Series B, Series A
OrbiMedSeries C, Series B Extension
Legend CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2026

    Led by Legend Capital with participation from OrbiMed and BioTrack Capital.

  • Jan 5, 2022

    BioTrack Capital led the Series A round.

Hangzhou Sneuro Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hangzhou Sneuro Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hangzhou Sneuro Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Year Founded2018
Last FundingMar 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?